Carlos Barrios
卡洛斯·巴里奥斯
MD
Director, Oncology Research Center & ESMO Latin America Chair肿瘤研究中心主任兼欧洲肿瘤学会拉丁美洲主席
👥Biography 个人简介
Carlos Barrios is one of Latin America's most prominent breast cancer trialists, directing PUCRS's oncology research center in Porto Alegre. As ESMO Latin America Chair, he has bridged European and Latin American oncology communities, led groundbreaking trials in HER2+ and triple-negative breast cancer, and trained a generation of Brazilian oncologists.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Breast Cancer Clinical Trials
Principal investigator for landmark trials including CLEOPATRA, EMILIA, and MARIANNE, making PUCRS one of the highest-enrolling Latin American sites in global HER2+ breast cancer studies.
ESMO Latin America Leadership
As ESMO Latin America Chair, established regional educational programs, guideline adaptations, and fellowship schemes that have trained 500+ oncologists across the region.
Real-World Evidence Generation
Led Brazilian and Latin American real-world evidence studies on breast cancer outcomes, treatment patterns, and access disparities informing national health policy.
Representative Works 代表性著作
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer (CLEOPATRA): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
The Lancet Oncology (2015)
Pivotal phase III trial establishing pertuzumab+trastuzumab as first-line standard of care in HER2+ mBC; Barrios was a key PI for Latin American sites.
Breast cancer in Latin America: current situation and future perspectives
Breast (2018)
Comprehensive review of breast cancer epidemiology, treatment access, and research capacity across Latin America with actionable recommendations.
Trastuzumab emtansine (T-DM1) versus capecitabine plus lapatinib in HER2-positive metastatic breast cancer (EMILIA): a descriptive analysis of final overall survival results
The Lancet Oncology (2017)
Final OS analysis of the EMILIA trial confirming long-term survival benefit of T-DM1 in previously treated HER2+ mBC.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 卡洛斯·巴里奥斯 的研究动态
Follow Carlos Barrios's research updates
留下邮箱，当我们发布与 Carlos Barrios（Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) / ESMO Latin America）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment